Published in Emerg Infect Dis on November 01, 2005
Detection of Group 1 Trypanosoma brucei gambiense by loop-mediated isothermal amplification. J Clin Microbiol (2011) 1.01
Human African trypanosomiasis in endemic populations and travellers. Eur J Clin Microbiol Infect Dis (2011) 0.91
Urban transmission of human African trypanosomiasis, Gabon. Emerg Infect Dis (2012) 0.84
Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser (1998) 3.93
[Infectious mononucleosis or sleeping sickness?]. Ann Biol Clin (Paris) (2000) 1.45
Cluster of African trypanosomiasis in travelers to Tanzanian national parks. Emerg Infect Dis (2002) 1.28
IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test. Trop Med Int Health (2002) 1.25
The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside Africa. Lancet Infect Dis (2003) 1.06
[Polyneuritis and myositis in Trypanosoma gambiense infection]. Dtsch Med Wochenschr (1994) 0.94
A traveler returning from Central Africa with fever and a skin lesion. Clin Infect Dis (1999) 0.90
Diagnosing multiple parasitic infections: trypanosomiasis, loiasis and schistosomiasis in a single case. Scand J Infect Dis (1991) 0.88
[African sleeping sickness in The Netherlands]. Ned Tijdschr Geneeskd (1995) 0.83
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-2002. A 37-year-old man with fever, hepatosplenomegaly, and a cutaneous foot lesion after a trip to Africa. N Engl J Med (2002) 0.83
An unusual course of west African trypanosomiasis in a Caucasian man. Trans R Soc Trop Med Hyg (1987) 0.82
[Uveo-meningitis revealing a West African trypanosomiasis in a 12-year-old girl]. Arch Fr Pediatr (1990) 0.81
[Human African trypanosomiasis from Trypanosoma brucei gambiense with inoculation chancre in a French expatriate]. Med Trop (Mars) (2001) 0.81
[Sleeping sickness as an import pathology following a stay in Zaire]. Acta Clin Belg (1996) 0.80
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis (2012) 4.62
Imported Chikungunya Infection, Italy. Emerg Infect Dis (2007) 2.08
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med (2013) 1.74
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? Antivir Ther (2004) 1.65
2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg (2013) 1.65
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Clin Pharmacokinet (2007) 1.47
Reactivation of Chagas disease after a bone marrow transplant in Italy: first case report. Blood Transfus (2012) 1.46
Acute strongyloidiasis in Italian tourists returning from Southeast Asia. J Travel Med (2011) 1.46
Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin Pharmacokinet (2005) 1.45
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies. Clin Infect Dis (2012) 1.45
Schistosomiasis Screening of Travelers from Italy with Possible Exposure in Corsica, France. Emerg Infect Dis (2015) 1.42
The role of rapid diagnostic tests in managing malaria. PLoS Med (2009) 1.39
Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art. Expert Rev Anti Infect Ther (2013) 1.36
Strongyloides stercoralis: a plea for action. PLoS Negl Trop Dis (2013) 1.33
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections. World J Emerg Surg (2011) 1.29
Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis. PLoS Negl Trop Dis (2011) 1.26
Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study. World J Emerg Surg (2012) 1.24
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project. Haematologica (2011) 1.23
Evaluation of an indirect immunofluorescence assay for strongyloidiasis as a tool for diagnosis and follow-up. Clin Vaccine Immunol (2006) 1.19
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients. Antimicrob Agents Chemother (2009) 1.17
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. J Antimicrob Chemother (2012) 1.16
Imported malaria in adults and children: epidemiological and clinical characteristics of 380 consecutive cases observed in Verona, Italy. J Travel Med (2008) 1.16
HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiation. Biochem Biophys Res Commun (2010) 1.12
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis. Antimicrob Agents Chemother (2010) 1.11
Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter? Crit Care (2009) 1.11
Therapy of uncomplicated falciparum malaria in Europe: MALTHER - a prospective observational multicentre study. Malar J (2012) 1.10
Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient. Clin Infect Dis (2006) 1.09
Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages. Clin Pharmacokinet (2004) 1.07
Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy. Medicine (Baltimore) (2014) 1.05
Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections. Int J Infect Dis (2010) 1.05
The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida. Virulence (2012) 1.03
Epidemiology, diagnosis and treatment of Clostridium difficile infection. Expert Rev Anti Infect Ther (2012) 1.03
Surveillance of hospital-acquired infections: a model for settings with resource constraints. Am J Infect Control (2006) 1.03
Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia. Am J Hematol (2006) 1.03
The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients? Clin Infect Dis (2006) 1.02
Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database. J Antimicrob Chemother (2013) 1.02
Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge. Eur Heart J (2007) 1.00
Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy). J Travel Med (2008) 0.99
FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging (2012) 0.98
Schistosomiasis Screening of Travelers to Corsica, France. Emerg Infect Dis (2016) 0.98
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure. Antimicrob Agents Chemother (2005) 0.98
Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose. J Antimicrob Chemother (2003) 0.98
An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol Reprod Biol (2003) 0.97
Cost-effectiveness analysis of initial HIV treatment under Italian guidelines. Clinicoecon Outcomes Res (2011) 0.97
Pathotype and susceptibility profile of a community-acquired methicillin-resistant Staphylococcus aureus strain responsible for a case of severe pneumonia. Diagn Microbiol Infect Dis (2009) 0.97
Imported malaria in immigrants to Italy: a changing pattern observed in north eastern Italy. J Travel Med (2009) 0.96
Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI). BMC Infect Dis (2014) 0.95
Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients. Scand J Infect Dis (2011) 0.95
Chlamydia trachomatis genital infection in migrant female sex workers in Italy. Int J STD AIDS (2003) 0.94
Cat-to-human orthopoxvirus transmission, northeastern Italy. Emerg Infect Dis (2009) 0.93
Amebic infections due to the Entamoeba histolytica-Entamoeba dispar complex: a study of the incidence in a remote rural area of Ecuador. Am J Trop Med Hyg (2002) 0.92
Population-based surveillance of infectious endocarditis in an Italian region. Arch Intern Med (2009) 0.92
Prevention of infections in cardiovascular implantable electronic devices beyond the antibiotic agent. J Cardiovasc Med (Hagerstown) (2014) 0.92
Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart Registry. Arch Intern Med (2011) 0.92
Nosocomial pulmonary infections in HIV-positive patients. Curr Opin Pulm Med (2005) 0.92
Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies. Eur J Haematol (2005) 0.91
Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach. Antimicrob Agents Chemother (2012) 0.90
Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. Clin Exp Nephrol (2013) 0.89
Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors. Clin Infect Dis (2002) 0.89
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitors. HIV Clin Trials (2012) 0.87
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective. J Antimicrob Chemother (2006) 0.87
Aggressive versus conservative initiation of antibiotics. Lancet Infect Dis (2013) 0.86
Should the currently recommended twice-daily dosing still be considered the most appropriate regimen for treating MRSA ventilator-associated pneumonia with vancomycin? Clin Pharmacokinet (2008) 0.86
Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line. New Microbiol (2010) 0.86
Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir. Scand J Infect Dis (2012) 0.86
Complicated intra-abdominal infections in Europe: preliminary data from the first three months of the CIAO Study. World J Emerg Surg (2012) 0.85
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells. Retrovirology (2011) 0.85
Trends in antibiotic sensitivity pattern and molecular detection of tet(O)-mediated tetracycline resistance in campylobacter jejuni isolates from human and poultry sources. Jpn J Infect Dis (2008) 0.84
Rhabdomyolysis due to Lamivudine administration in a liver transplant recipient. Am J Transplant (2005) 0.84
Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections. Expert Rev Anti Infect Ther (2007) 0.84
Human granulocytic anaplasmosis in northeastern Italy. Ann N Y Acad Sci (2006) 0.83
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases. Am J Kidney Dis (2004) 0.83
Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy. Antimicrob Agents Chemother (2012) 0.83
Mefloquine versus quinine plus sulphalene-pyrimethamine (metakelfin) for treatment of uncomplicated imported falciparum malaria acquired in Africa. Antimicrob Agents Chemother (2005) 0.83
A risk prediction score for invasive mold disease in patients with hematological malignancies. PLoS One (2013) 0.82
Sickle cell disease and hyperreactive malarial splenomegaly (HMS) in young immigrants from Africa. Blood (2005) 0.81
First description of Trypanosoma cruzi human infection in Esmeraldas province, Ecuador. Parasit Vectors (2014) 0.81
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients. Mycoses (2012) 0.81
Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B. J Travel Med (2008) 0.81
Tickborne encephalitis virus, northeastern Italy. Emerg Infect Dis (2006) 0.81
Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk. AIDS Res Hum Retroviruses (2012) 0.81
Acute pancreatitis after kidney transplantation. Am J Gastroenterol (2005) 0.81